Free Trial

Nykode Therapeutics AS (VACBF) Short Interest Ratio & Short Volume

$0.24 0.00 (0.00%)
As of 01/29/2025

Nykode Therapeutics AS Short Interest Data

Nykode Therapeutics AS (VACBF) has a short interest of 2.20 million shares. This marks a -1.79% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 2,980 shares to cover all short positions.

Current Short Interest
2,199,700 shares
Previous Short Interest
2,239,800 shares
Change Vs. Previous Month
-1.79%
Dollar Volume Sold Short
$529,687.76
Short Interest Ratio
0.0 Days to Cover
Last Record Date
January 15, 2025
Today's Trading Volume
0 shares
Average Trading Volume
2,980 shares
Today's Volume Vs. Average
0%
Short Selling Nykode Therapeutics AS?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Nykode Therapeutics AS and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VACBF Short Interest Over Time

VACBF Days to Cover Over Time

VACBF Percentage of Float Shorted Over Time

Nykode Therapeutics AS Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/20252,199,700 shares $529,687.76 -1.8%N/A0 $0.24
12/31/20242,239,800 shares $539,343.84 No ChangeN/A0 $0.24
12/15/20242,239,800 shares $539,343.84 +2.7%N/A0 $0.24
11/30/20242,180,200 shares $524,992.16 -1.0%N/A908.4 $0.24
11/15/20242,203,200 shares $694,008.00 -0.3%N/A4406.4 $0.32
10/31/20242,210,700 shares $1.15 million No ChangeN/A0 $0.52
10/15/20242,210,700 shares $1.15 million -1.9%N/A0 $0.52
9/30/20242,252,400 shares $1.17 million -2.2%N/A0 $0.52
9/15/20242,303,400 shares $1.20 million -2.9%N/A23034 $0.52
8/31/20242,371,000 shares $1.25 million +2.2%N/A3951.7 $0.53
8/15/20242,319,400 shares $3.48 million +1.1%N/A0 $1.50
7/31/20242,294,900 shares $3.44 million +10.4%N/A0 $1.50
7/15/20242,078,700 shares $3.12 million +5.1%N/A0 $1.50
6/30/20241,977,700 shares $2.97 million -1.2%N/A0 $1.50
6/15/20242,002,400 shares $3.00 million No ChangeN/A0 $1.50
5/31/20242,002,400 shares $3.00 million +7.9%N/A0 $1.50
5/15/20241,855,700 shares $2.78 million -0.6%N/A976.7 $1.50
4/30/20241,866,300 shares $2.33 million +6.7%N/A0 $1.25
4/15/20241,748,600 shares $2.19 million +7.7%N/A17486 $1.25
3/31/20241,623,000 shares $2.56 million -14.0%N/A16230 $1.58
3/15/20241,887,300 shares $2.98 million +77.3%N/A419.4 $1.58
2/29/20241,064,500 shares $1.68 million -9.1%N/A0 $1.58
2/15/20241,171,600 shares $1.85 million +26.3%N/A0 $1.58
1/15/2024768,100 shares $1.21 million +15.5%N/A0 $1.58
12/31/2023664,800 shares $1.05 million +12.1%N/A0 $1.58
12/15/2023593,100 shares $937,098.00 No ChangeN/A0 $1.58
11/30/2023593,100 shares $937,098.00 -30.2%N/A0 $1.58
11/15/2023849,200 shares $1.34 million -67.0%N/A0 $1.58
10/31/20232,576,500 shares $4.07 million -0.1%N/A25765 $1.58
10/15/20232,578,600 shares $5.80 million +5.3%N/A25786 $2.25
9/30/20232,448,000 shares $5.78 million +0.9%N/A0 $2.36
9/15/20232,426,800 shares $5.73 million +1.9%N/A0 $2.36
8/31/20232,382,800 shares $5.62 million No ChangeN/A0 $2.36

VACBF Short Interest - Frequently Asked Questions

What is Nykode Therapeutics AS's current short interest?

Short interest is the volume of Nykode Therapeutics AS shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 2,199,700 shares of VACBF short. Learn More on Nykode Therapeutics AS's current short interest.

Is Nykode Therapeutics AS's short interest increasing or decreasing?

Nykode Therapeutics AS saw a decline in short interest during the month of January. As of January 15th, there was short interest totaling 2,199,700 shares, a decline of 1.8% from the previous total of 2,239,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Nykode Therapeutics AS stock?

Short selling VACBF is an investing strategy that aims to generate trading profit from Nykode Therapeutics AS as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Nykode Therapeutics AS?

A short squeeze for Nykode Therapeutics AS occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VACBF, which in turn drives the price of the stock up even further.

How often is Nykode Therapeutics AS's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VACBF, twice per month. The most recent reporting period available is January, 15 2025.




This page (OTCMKTS:VACBF) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners